期刊文献+

苯丙氨酸解氨酶合成L-2-氯苯丙氨酸的研究

Synthesis of 2-chloro-L-phenylalanine by Phenylalanine Ammonia Lyase
下载PDF
导出
摘要 L-2-氯苯丙氨酸要求旋光对映体过量(ee)≥98%,导致使用化学拆分法合成L-2-氯苯丙氨酸的收率不足50%。为提高收率,文章采用具有立体专一性的苯丙氨酸解氨酶(PAL),催化邻氯肉桂酸与氨合成L-2-氯苯丙氨酸,旋光对映体过量(ee)>99%。通过考察不同形态PAL酶的稳定性,研究得出全细胞冻融法制作的PAL酶稳定性较好,结合氮气保护,反应80 h依然能保留62%的酶活。同时,优化PAL酶催化反应的pH、温度、酶用量,确定最佳条件后,结合分段补料的方式进行酶催化反应,最终使L-2-氯苯丙氨酸的累积量达到了68.5 g/L,转化率达到了97.8%。该技术合成L-2-氯苯丙氨酸的产量和收率较高,有效降低了成本,提升了L-2-氯苯丙氨酸的市场价值。 The synthesis yield of 2-chloro-L-phenylalanine by chemical resolution is less than 50%,due to the requirement of optically active enantiomer excess(ee)逸98%.In order to improve the yield,this article uses a stereospecific phenylalanine ammonia lyase(PAL)to catalyze the synthesis of 2-chloro-L-phenylalanine from 2-chlorocinnamic acid and ammonia,the product with an optically active enantiomer excess(ee)>99%.By investigating the enzyme stability of different forms of PAL,it finds that the stability of PAL produced by whole cell freeze-thaw method is better.Combined with nitrogen protection,the enzyme remains 62%active after 80 hours of reaction.The antioxidant activity of the enzyme is Successfully improved and the effective reaction time is prolonged.At the same time,this study optimizes the pH value,temperature,enzyme dosage for PAL catalysis,and after determining the best conditions,carries out the enzyme catalyze reaction in combination with the method of fractional feeding.Finally,the high yield of 2-chloro-L-phenylalanine achieves 68.5 g/L,with the conversion rate of 97.8%.The synthetic output and yield of 2-chloro-L-phenylalanine by using this technology are relatively high,which effectively reduces the cost and enhances the market value of 2-chloro-L-phenylalanine.
作者 余玉奎 周丽 YU Yukui;ZHOU Li(Yusong Biotechnology Co.Ltd.,Shanghai 200000,China)
出处 《工业微生物》 CAS 2024年第5期93-96,共4页 Industrial Microbiology
关键词 苯丙氨酸解氨酶(PAL) L-2-氯苯丙氨酸 全细胞催化 氮气保护 phenylalanine ammonia lyase(PAL) 2-chloro-L-phenylalanine whole cell catalysis nitrogen protection
  • 相关文献

参考文献2

二级参考文献21

  • 1钱超,张家森,刘建青,李鲁祯,陈新志.S-(-)-2-羧基吲哚啉的制备研究[J].高校化学工程学报,2006,20(3):422-427. 被引量:6
  • 2Andre V,Cunha-silva L,Duarte MT,et al.First crystal st-ructures of the antihypertensive drug perindopril erbu-mine:a novel hydrated form and polymorphsαandβ[J].Crystal Growth&Design,2011,11(9):3703.
  • 3Remko M.Molecular structure and stability of perindopril erbumine and perindopril L-arginine complexes[J].Eur J Med Chem,2009,44(1):101.
  • 4Ferrari R.Angiotensin-converting enzyme inhibition in ca-rdiovascular disease:evidence with perindopril[J].Expert Rev Cardiovasc Ther,2005,3(1):15.
  • 5Ionescu DD,PREFER Investigators.Antihypertensive effi-cacy of perindopril5-10mg/day in primary health care:an open-label,prospective,observational study[J].Clin Drug Investig,2009,29(12):767.
  • 6Louis WJ.Comparision of the pharmacokinefics and phat-maeodynamics of perindopril,cilazapril and enalapril[J].Clin Exp Pharmacol Physiol,1992,19(suppl19):55.
  • 7Vincent M,Remond G.Substituted iminodiacids,their pr-eparation and pharmaceutical compositions containing them:US,4508729[P].1985-04-02.
  • 8Mezei T,Porcs M.Method for synthesis of(2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole2-carboxylic ac-id derivatives and use in the synthesis of perindopril:EP,1256590[P].2002-11-13.
  • 9Cid P.A process for the preparation of perindopril,its analogous compounds and salts thereof using2,5-di-oxo-oxazolidine intermediate compounds:EP,1279665[P].2003-01-29.
  • 10Serra M,Palomo C.N-Sulfoxy anhydrides,a process for the preparation there of and its use for the preparation of bioactive substances having ace inhibitory action:WO,9633984[P].1996-10-31.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部